Liqing Jin

Toronto, ON M5G1L7, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 05, 2026

Human haematopoietic stem cells remember inflammatory stress.

Human haematopoietic stem cells remember inflammatory stress.

Journal: Nature
Published: September 18, 2024

Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Response to Immune Checkpoint Blockade Is Enhanced in the Presence of Hematopoietic TET2 Inactivation.

Journal: Cancer research
Published: September 12, 2024

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells.

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells.

Journal: Blood
Published: June 21, 2024

Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia.

Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia.

Journal: Cancer discovery
Published: December 13, 2022

KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.

KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.

Journal: Leukemia
Published: September 14, 2022

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.

A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.

Journal: Nature medicine
Published: July 27, 2021

A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo.

A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells in vitro and in vivo.

Journal: Haematologica
Published: June 23, 2021

Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation.

Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation.

Journal: Blood cancer discovery
Published: January 18, 2021

Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target.

Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target.

Journal: Blood cancer discovery
Published: December 03, 2020

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells.

CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells.

Journal: Blood
Published: August 17, 2020

CD200 expression marks leukemia stem cells in human AML.

CD200 expression marks leukemia stem cells in human AML.

Journal: Blood advances
Published: March 03, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026